메뉴 건너뛰기
Neurological Sciences
Volumn 32, Issue 1, 2011, Pages 181-182
Association of melanoma and natalizumab therapy in the Italian MS population: A second case report
Author keywords

Melanoma; Multiple sclerosis; Natalizumab
Indexed keywords

ALPHA4 INTEGRIN; BETA1A INTERFERON; NATALIZUMAB;
EID: 79551586049     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-010-0427-x     Document Type: Article
Times cited : (27)
References (11)
  • 1
    • 33644584352 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
    • 1:CAS:528:DC%2BD28XitVertL4%3D 10.1056/NEJMoa044397 16510744
    • CH Polman PW O'Connor E Havrdova, et al. 2006 A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 899 910 1:CAS:528:DC%2BD28XitVertL4%3D 10.1056/NEJMoa044397 16510744
    • (2006) N Engl J Med , vol.354 , pp. 899-910
    • Polman, C.H.1    O'Connor, P.W.2    Havrdova, E.3
  • 2
    • 70349652532 scopus 로고    scopus 로고
    • Melanoma complicating treatment with natalizumab (tysabri) for multiple sclerosis
    • 10.1007/s00415-009-5200-9 19609591
    • A Ismail J Kemp B Sharrack 2009 Melanoma complicating treatment with natalizumab (tysabri) for multiple sclerosis J Neurol 256 1771 1772 10.1007/s00415-009-5200-9 19609591
    • (2009) J Neurol , vol.256 , pp. 1771-1772
    • Ismail, A.1    Kemp, J.2    Sharrack, B.3
  • 3
    • 38949166754 scopus 로고    scopus 로고
    • Melanoma complicating treatment with natalizumab for multiple sclerosis
    • 1:CAS:528:DC%2BD1cXhs1enu78%3D 10.1056/NEJMc0706103 18256405
    • JT Mullen TK Vartanian MB Atkins 2008 Melanoma complicating treatment with natalizumab for multiple sclerosis N Engl J Med 358 647 648 1:CAS:528:DC%2BD1cXhs1enu78%3D 10.1056/NEJMc0706103 18256405
    • (2008) N Engl J Med , vol.358 , pp. 647-648
    • Mullen, J.T.1    Vartanian, T.K.2    Atkins, M.B.3
  • 4
    • 72749090843 scopus 로고    scopus 로고
    • Melanoma in multiple sclerosis treated with natalizumab: Causal association or coincidence?
    • 1:CAS:528:DC%2BC3cXhtlaqsrg%3D 10.1177/1352458509347154 20019096
    • R Bergamaschi C Montomoli 2009 Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence? Mult Scler 15 1532 1533 1:CAS:528:DC%2BC3cXhtlaqsrg%3D 10.1177/1352458509347154 20019096
    • (2009) Mult Scler , vol.15 , pp. 1532-1533
    • Bergamaschi, R.1    Montomoli, C.2
  • 5
    • 46449083260 scopus 로고    scopus 로고
    • More on melanoma with transdifferentiation
    • 1:CAS:528:DC%2BD1cXotFChtbg%3D 10.1056/NEJMc086089 18596284 author reply 99-100
    • MA Panzara C Bozic AW Sandrock 2008 More on melanoma with transdifferentiation N Engl J Med 359 99 1:CAS:528:DC%2BD1cXotFChtbg%3D 10.1056/NEJMc086089 18596284 author reply 99-100
    • (2008) N Engl J Med , vol.359 , pp. 99
    • Panzara, M.A.1    Bozic, C.2    Sandrock, A.W.3
  • 6
    • 62849084585 scopus 로고    scopus 로고
    • Melanoma following treatment with alemtuzumab for multiple sclerosis
    • 1:STN:280:DC%2BD1M3mtVKhsQ%3D%3D 10.1111/j.1468-1331.2009.02552.x 19222552
    • AA Pace JP Zajicek 2009 Melanoma following treatment with alemtuzumab for multiple sclerosis Eur J Neurol 16 e70 e71 1:STN:280:DC%2BD1M3mtVKhsQ%3D%3D 10.1111/j.1468-1331.2009.02552.x 19222552
    • (2009) Eur J Neurol , vol.16
    • Pace, A.A.1    Zajicek, J.P.2
  • 7
    • 34047254327 scopus 로고    scopus 로고
    • Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies
    • 10.1016/j.jaad.2006.12.024 17434043
    • GJ Fulchiero Jr H Salvaggio JJ Drabick, et al. 2007 Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies J Am Acad Dermatol 56 S65 S67 10.1016/j.jaad.2006.12.024 17434043
    • (2007) J Am Acad Dermatol , vol.56
    • Fulchiero Jr., G.J.1    Salvaggio, H.2    Drabick, J.J.3
  • 8
    • 21544479745 scopus 로고    scopus 로고
    • Integrin signaling in malignant melanoma
    • 1:CAS:528:DC%2BD2MXls1agsLY%3D 10.1007/s10555-005-1572-1 15986132
    • S Kuphal R Bauer AK Bosserhoff 2005 Integrin signaling in malignant melanoma Cancer Metastasis Rev 24 195 222 1:CAS:528:DC%2BD2MXls1agsLY%3D 10.1007/s10555-005-1572-1 15986132
    • (2005) Cancer Metastasis Rev , vol.24 , pp. 195-222
    • Kuphal, S.1    Bauer, R.2    Bosserhoff, A.K.3
  • 9
    • 33744957048 scopus 로고    scopus 로고
    • Regulation of integrin activity by MIA
    • 1:CAS:528:DC%2BD28Xjsleguro%3D 10.1074/jbc.M511367200 16517605
    • R Bauer M Humphries R Fassler A Winklmeier SE Craig AK Bosserhoff 2006 Regulation of integrin activity by MIA J Biol Chem 281 11669 11677 1:CAS:528:DC%2BD28Xjsleguro%3D 10.1074/jbc.M511367200 16517605
    • (2006) J Biol Chem , vol.281 , pp. 11669-11677
    • Bauer, R.1    Humphries, M.2    Fassler, R.3    Winklmeier, A.4    Craig, S.E.5    Bosserhoff, A.K.6
  • 10
    • 0028175008 scopus 로고
    • Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation
    • 1:CAS:528:DyaK2cXjt1Snsbw%3D 10.1016/0092-8674(94)90149-X 8181055
    • F Qian DL Vaux IL Weissman 1994 Expression of the integrin alpha 4 beta 1 on melanoma cells can inhibit the invasive stage of metastasis formation Cell 77 335 347 1:CAS:528:DyaK2cXjt1Snsbw%3D 10.1016/0092-8674(94)90149-X 8181055
    • (1994) Cell , vol.77 , pp. 335-347
    • Qian, F.1    Vaux, D.L.2    Weissman, I.L.3
  • 11
    • 33846185607 scopus 로고    scopus 로고
    • Melanoma incidence in central Italy will go on increasing also in the near future: A registry-based, age-period-cohort analysis
    • 10.1097/01.cej.0000220634.31223.f7 17220704
    • E Crocetti P Carli G Miccinesi 2007 Melanoma incidence in central Italy will go on increasing also in the near future: a registry-based, age-period-cohort analysis Eur J Cancer Prev 16 50 54 10.1097/01.cej.0000220634. 31223.f7 17220704
    • (2007) Eur J Cancer Prev , vol.16 , pp. 50-54
    • Crocetti, E.1    Carli, P.2    Miccinesi, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.